February 08, 2013

Have you ever seen a case of cefepime-induced neurotoxicity in dialysis patients?

The antibiotic cefepime can be cause neurotoxicity in dialysis patients, and cases have been reported in the literature.

For example, researchers in Taiwan reported a case of an 80-year-old women with chronic renal failure on peritoneal dialysis who experienced encephalopathy induced by the antibiotic (J Chin Med Assoc 2011;74:87-90). Italian researchers reported a case of an 82-year-old man on chronic hemodialysis who experienced a seizure four days after starting cefepime treatment (Clin Nephrol 2003;59:388-390).

Renal & Urology News would like to know gauge nephrologists' awareness of cefepime-induced neurotoxicyt in dialysis patients, so please answer the following poll question.


Related Articles
Related Topics

More in Polls & Surveys

Should kidney transplant programs provide long-term follow-up of living kidney donors?

A number of single-center studies show that living kidney donation is associated with minimal morbidity and mortality.

Is screening for cancer warranted following a kidney transplant?

Improvements in immunosuppressive therapy have resulted in longer survival of kidney transplants, but they also may increase malignancies.

Is radium-223 a game-changer for treatment of CRPC with symptomatic bone metastases?

This week, the FDA approved radium-223 injection for the treatment of CRPC with symptomatic bone metastases.